Read the official EDE Circular No. 46/2026 and download the full regulatory document in the TOP-Pharma Resource Centre. The Emirates Drug Establishment (EDE) has introduced a comprehensive regulatory framework for peptide products and substances under Circular No. 46/2026, Guideline for Handling Peptide Products and Molecules, issued on 5 November 2026. The 26-page document establishes requirements for regulatory approval, importation, pharmaceutical compounding, quality control, storage, traceability and the use of peptide-containing products in the United Arab Emirates. The circular applies to medical products intended for clinical research, raw materials intended for pharmaceutical...